This 2-year Fellowship provides a unique opportunity to work in two of the most exciting areas of medical research and pharmaceutical development today: Immunology and Immuno-Oncology. Individuals participating in this fellowship will gain a broad understanding of Medical Affairs through both participatory and leadership experiences from the perspective of the US Medical Strategy Team in Immunology, and subsequently from the perspective of the Global Scientific Communications team in Immuno-Oncology. Graduates of this fellowship have gone on to work in various aspects of Medical Affairs; ie Medical Strategy, Global Scientific Communications, Medical Science Liaison, Medical Information, and Independent Medical Education.
IMMUNOLOGY US MEDICAL STRATEGY
Participate in strategic planning with the US Medical Matrix Team based on unmet medical needs from the perspectives of patients, providers, and payers
Lead medical projects in partnership with the broader medical matrix team members (Field Medical, Medical Information, Independent Medical Education, Sales, Marketing, Outcomes Research, Promotion Integrity, Legal, and Global Pharmacovigilance & Epidemiology)
Lead and participate in key aspects of medical affairs including data generation, content development, training, and insight identification including advisory boards and Medical Science Liaison interactions
Conduct medical review of promotional and non-promotional materials in collaboration with Legal, Regulatory, and Marketing teams
IMMUNO-ONCOLOGY GLOBAL SCIENTIFIC COMMUNICATIONS
Develop a comprehensive and globally aligned strategic publication plan by identifying key scientific data gaps and collaborating closely with a cross-matrix team including: Global Medical Strategy Lead, Clinical Research Lead, Statisticians, Senior Leadership, and External Thought Leaders
Lead development of publication deliverables (e.g. manuscripts, abstracts, posters, oral presentations) and execution of related activities at congresses
Lead scientific content development, including Q&As, Core Modules, and Standard Response Documents in collaboration with Global Medical Strategy Lead and Global Field Medical Communications
Ensure clear scientific communication of data as well as incorporation of key stakeholder input
Develop therapeutic expertise in Immuno-Oncology
Please consider attending Fellowship Information and Network Day here at Rutgers Ernest Mario School of Pharmacy on November 22nd from 3:30 PM – 8:00 PM so we can visit with you about your interests. For additional information please visit our website: http://pharmafellows.rutgers.edu/applicants/fid.php.
We do not pre-schedule interviews for Midyear, so please do not request an interview via this website. Your emails will not be reviewed.
We will be scheduling interviews starting at 10 AM on December 7th. Prior to scheduling an interview you will need to view the Fellowship information video
Rutgers, The State University of New Jersey, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, gender identity or expression, disability, age, or any other category covered by law in its admission, programs, activities, or employment matters. The following people have been designated to handle inquiries regarding the nondiscrimination policies: Judy Ryan, Universitywide Title IX Coordinator, Office of Enterprise Risk Management, Ethics, and Compliance (732-235-5304, firstname.lastname@example.org); and Lisa Grosskreutz, Director, Office of Employment Equity, University Human Resources (848-932-3980, email@example.com). For further information on the notice of nondiscrimination, you may contact the U.S. Department of Education, Office for Civil Rights, at 646-428-3900 or OCR.NewYork@ed.gov.
The Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, is dedicated to excellence in healthcare and biomedical education, innovative and visionary research and scholarship in the pharmaceutical sciences, exemplary clinical practice, and outreach and community services that address the needs of the citizens of New Jersey and society at large.
The School has a historic and profound commitment to public service – to pharmacists, the pharmaceutical industry, the health care community, government agencies, and the citizens of New Jersey.